 SAN DIEGO, Feb. 03, 2021 GLOBE NEWSWIRE -- Exagen Inc. Nasdaq: XGN, a leading autoimmune organization, today announced its participation in the BTIG MedTech, Digital Health, Life Science Diagnostic Tools Conference, which takes place February 17-19, 2021. Ron Rocca, Exagens President and Chief Executive Officer, and Kamal Adawi, Exagens Chief Financial Officer, will participate in a virtual fireside chat on Wednesday, February 17 at 3:00 PM ET, which is accessible to conference attendees. Management will also be participating in one-on-one meetings with investors during the event; meetings can be requested through BTIG. 